Management of asymptomatic hyperuricemia: Integrated Diabetes & Endocrine Academy (IDEA) consensus statement

Abstract

Aim: The definition and management of asymptomatic hyperuricemia has been an area of controversy for many decades. Debate persists regarding the benefit of treating all cases of asymptomatic hyperuricemia and hence, unsurprisingly there are no clear clinical practice guidelines from our country.

Participants: Ten members consisting of eminent physicians, endocrinologists, nephrologist and a rheumatologist were selected by the Integrated Diabetes & Endocrine Academy (IDEA) for a closed meeting with the aim to come to a consensus.

Evidence: A literature search was performed using PubMed and Cochrane library following which published articles in indexed peer review journals were selected.

Consensus process: Each participant voiced their opinion after reviewing the available data and a consensus was reached after three meetings by voting.

Conclusion: Recommendations were made on important areas such as definition, investigation and management of asymptomatic hyperuricemia.

Keywords: Hyperuricemia; Urate lowering therapy; Uric acid.